Actively Recruiting
Transcatheter Aortic Valve Replacement in Severe Low Flow, Low Gradient Aortic Stenosis
Led by University of Salerno · Updated on 2026-04-07
1350
Participants Needed
1
Research Sites
721 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
LOW-TAVR is a real-world, retrospective and prospective, multicenter Italian registry aimed at evaluating the characteristics and clinical outcomes of patients with severe low flow, low gradient aortic stenosis undergoing transcatheter aortic valve replacement (TAVR) and, in particular: * risk factors * gender differences * comorbidities * pharmacological treatment * TAVR procedural characteristics * periprocedural and in-hospital complications * clinical outcome at 30-day, 1-year, 2-year and 5-year follow-up
CONDITIONS
Official Title
Transcatheter Aortic Valve Replacement in Severe Low Flow, Low Gradient Aortic Stenosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with severe low flow, low gradient aortic stenosis according to current European Society of Cardiology guidelines
- Age 18 years or older
- Provided written informed consent
You will not qualify if you...
- Pseudo-severe or non-confirmed severe aortic stenosis
- Referred for medical treatment or undergoing surgery instead of TAVR
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Salerno
Salerno, Italy, 84131
Actively Recruiting
Research Team
G
Gennaro Galasso, MD, PhD
CONTACT
A
Angelo Silverio, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here